- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03221114
Positive Psychology Intervention for Spanish-speaking Hispanic/Latino Adults at Risk for Cardiovascular Disease
18. marts 2019 opdateret af: University of Illinois at Urbana-Champaign
The largest epidemiologic study of Hispanic/Latino participants thus far, i.e., the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) documented that 80% of men and 71% of women have at least one major cardiovascular disease (CVD) risk factor.
The American Heart Association emphasizes that current CVD prevention efforts are sparse and ineffectual in minority populations and acknowledges the need for new and more effective disease prevention strategies.
This observational study and pilot cluster-randomized clinical trial seeks to implement and evaluate a novel 8-week Positive Psychology (PP) Intervention (compared to an attention control condition) in Hispanic/Latino adults with uncontrolled hypertension, i.e., elevated 24-hour ambulatory blood pressure, with primary interest in testing efficacy for clinically meaningful improvements in cardiovascular function.
Studieoversigt
Status
Ukendt
Intervention / Behandling
Detaljeret beskrivelse
The study features piloting of a cluster-randomized trial to determine whether a positive psychology (PP) intervention is associated with greater improvements in blood pressure compared to an attention control condition.
The pilot trial additionally evaluates the efficacy of the PP intervention with respect to psychological well-being, hypertension-related health behaviors, autonomic cardiac control, and high-sensitivity C-reactive protein.
Serum blood assays will facilitate exploration of mechanistic indicators linking psychological well-being to cardiac functioning.
Undersøgelsestype
Interventionel
Tilmelding (Forventet)
126
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60608
- Rekruttering
- St. Pius V Parish
-
Kontakt:
- Jose M Santiago
- Telefonnummer: 312-226-6161
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Hispanics/Latinos recruited from Catholic church sites in Chicago-land area
- aged ≥18
- fluent in English or Spanish with ≥8th grade education
- elevated 24-hour ambulatory blood pressure levels (systolic BP> 140 mmHg and >90 mmHg for diastolic BP).
Exclusion Criteria:
- Unavailable for study period; have cognitive impairment denoting dementia
- have severely reduced life expectancy
- are currently enrolled in psychotherapy or take prescribed antidepressants
- history or current diagnosis of bipolar disorder, dissociative disorder, psychosis, or substance abuse
- have severe depression.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Positive Psychological Intervention
Our culturally-tailored Positive Psychology (PP) Intervention is a non-pharmacotherapy approach aimed at increasing positive emotional experiences by teaching individuals to engage in intentional activities known to increase psychological and emotional well-being through targeting of constructs such as optimism, gratitude, mindfulness/relaxation, and resilience.
|
Our culturally-tailored Positive Psychology Intervention is a non-pharmacotherapy approach aimed at increasing positive emotional experiences by teaching individuals to engage in intentional activities known to increase psychological and emotional well-being through targeting of constructs such as optimism, gratitude, mindfulness/relaxation, and resilience.
Andre navne:
|
|
Ingen indgriben: Wait list control
Receipt after the active treatment group has completed the positive psychological intervention.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from Baseline Ambulatory Blood Pressure at 8- and 12-weeks
Tidsramme: Baseline, 8-, and 12-weeks
|
The device, Vitavue, consists of a wireless microcontroller that connects to a desktop computer running proprietary software when operated in real time connected mode.
Alternatively, it can be operated in standalone unconnected mode by logging acquired data to an internal memory storage device.
The device contains a number of sensors including ECG single channel amplifier, Multispectral Photodiode to record photo pulse plethysmograms, temperature sensor to measure skin temperature, and an accelerometer to record the level of activity.
|
Baseline, 8-, and 12-weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Center for Epidemiological Studies Depression Scale (CESD): Change from Baseline Depressive Symptoms at 8- and 12-weeks
Tidsramme: Baseline, 8-, and 12-weeks
|
Center for Epidemiological Studies Depression-Scale
|
Baseline, 8-, and 12-weeks
|
|
Life Orientation Test-Revised (LOT-R): Change from Baseline Dispositional Optimism at 8- and 12-weeks
Tidsramme: Baseline, 8-, and 12-weeks
|
Life Orientation Test-Revised
|
Baseline, 8-, and 12-weeks
|
|
General Well-being Schedule: Change in Baseline Emotional Vitality at 8- and 12-weeks
Tidsramme: Baseline, 8-, and 12-weeks
|
General Well-being Schedule
|
Baseline, 8-, and 12-weeks
|
|
Life Engagement Test (LET): Change in Baseline Life engagement and Meaning at 8- and 12-weeks
Tidsramme: Baseline, 8-, and 12-weeks
|
Life Engagement Test
|
Baseline, 8-, and 12-weeks
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Physical Activity: Change in Hypertension-related Health Behavior(s)
Tidsramme: Baseline, 8-, and 12-weeks
|
Physical Activity using Fitbit One
|
Baseline, 8-, and 12-weeks
|
|
Diet: Change in Hypertension-related Health Behavior(s)
Tidsramme: Baseline, 8-, and 12-weeks
|
Diet using Scored Sodium Questionnaire
|
Baseline, 8-, and 12-weeks
|
|
Change in Heart Rate Variability
Tidsramme: Baseline, 8-, and 12-weeks
|
Beat-to-beat interval
|
Baseline, 8-, and 12-weeks
|
|
Change in High-sensitivity C-Reactive Protein
Tidsramme: Baseline, 8-, and 12-weeks
|
mg/L
|
Baseline, 8-, and 12-weeks
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. oktober 2017
Primær færdiggørelse (Forventet)
1. september 2020
Studieafslutning (Forventet)
1. juli 2021
Datoer for studieregistrering
Først indsendt
14. juni 2017
Først indsendt, der opfyldte QC-kriterier
13. juli 2017
Først opslået (Faktiske)
18. juli 2017
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
20. marts 2019
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
18. marts 2019
Sidst verificeret
1. marts 2019
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 1K01HL130712-01A1 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
JA
IPD-planbeskrivelse
We will make the data available to users only under a data-sharing agreement that provides for: (1) a commitment to use data only for research purposes and not to identify any individual participant; (2) a commitment to secure the data using appropriate technology; and (3) a commitment to destroy or return data after analyses are completed.
If additional outputs result from this research that would be appropriate to share with a wider audience, we will work with the Research Data Service at the University Library to determine appropriate venues for archiving and sharing.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kardiovaskulær risikofaktor
-
Ottawa Hospital Research InstituteAfsluttetStress | Crisis Resource Management (CRM) færdigheder | Advanced Cardiovascular Life Support (ACLS) færdighederCanada
-
Pakistan Institute of Living and LearningAfsluttetPsykose | At Risk Mental State (ARMS)Pakistan
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)AfsluttetFørste episode psykose (FEP) | At Risk Mental State (ARMS)Forenede Stater
-
Cairo UniversityShaimaa Mostafa; Yasmin Zakaria; Ibrahim Fawzy; Mona Aboulghar; Mona FouadAfsluttet
-
Tanta UniversityAfsluttet
-
The First Affiliated Hospital of Soochow UniversityRekrutteringCore Binding Factor Akut Myeloid Leukæmi | KIT-mutationsrelaterede tumorerKina
-
Taipei Medical University WanFang HospitalAfsluttetParonychia | Epidermal Growth Factor Receptor InhibitorTaiwan
-
Chang Gung Memorial HospitalAfsluttetParonychia | Epidermal Growth Factor Receptor InhibitorTaiwan
-
D.O. Ott Research Institute of Obstetrics, Gynecology...Aktiv, ikke rekrutterendeInfertilitet | Chlamydia Trachomatis-infektion | Antichlamydia antistoffer | Tubal Factor InfertilitetDen Russiske Føderation
-
University Hospital, Strasbourg, FranceRekrutteringHæmoragiske lidelser | Ekstrinsisk Pathway Factor Deficiency | Hepatocellulær insufficiens med koagulopatiFrankrig
Kliniske forsøg med Positive Psychological Intervention
-
Hospital Costa del SolIkke rekrutterer endnu
-
Pakistan Institute of Living and LearningAktiv, ikke rekrutterendeAutismespektrumforstyrrelse | SelvskadePakistan
-
Yangzhou UniversityAfsluttetIrritabelt tarmsyndrom | Psykologisk intervention | StigmaKina
-
Swiss Paraplegic Research, NottwilAfsluttetKronisk smerte | RygmarvsskadeSchweiz
-
University of Illinois at Urbana-ChampaignRosenfeld Heart Foundation GrantUkendtKardiovaskulær risikofaktor | Ukontrolleret hypertensionForenede Stater
-
SIMmersion, LLCTowson UniversityUkendtKønsbekræftende kommunikationsevnerForenede Stater
-
Brigham and Women's HospitalHarvard Medical School (HMS and HSDM)AfsluttetHæmatopoietisk/lymfoid kræft | Hæmatologisk malignitet | BlodkræftForenede Stater
-
Central South UniversityAfsluttet
-
Brigham and Women's HospitalNational Cancer Institute (NCI)AfsluttetHæmatopoietisk/lymfoid kræft | Hæmatologisk malignitet | BlodkræftForenede Stater
-
Brigham and Women's HospitalAfsluttetHæmatologisk malignitet | OmsorgsgiverForenede Stater